Promentis Pharmaceuticals to present at the Society for Neuroscience conference

Monday, October 29, 2018 Press Release
Email Print This Page Comment bookmark
Font : A-A+

MILWAUKEE, Wis., Oct. 29, 2018 /PRNewswire/ -- Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company

developing innovative therapies for neuropsychiatric disorders, announced today that Dr. Chad Beyer and Michael Neary will present key scientific data on SXC-2023, a novel activator of System
xc-, at the annual Society for Neuroscience meeting taking place November 3-7, 2018 in San Diego, California.

This presentation is scheduled for:Date: Wednesday, November 7, 2018 Title:  SXC-2023, a Potential Therapeutic for Various CNS Disorders, is Safe and Well-Tolerated in Phase 1 Clinical StudiesPoster Number: 684.06

About Promentis Pharmaceuticals Promentis Pharmaceuticals, Inc. is a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders. Promentis' drug development efforts are focused on a unique approach to address imbalances in glutamatergic neurotransmission and oxidative stress. The Company's first indication is trichotillomania, a highly prevalent disorder for which there is no approved therapy, and for which there are no other known treatments in development. For more information regarding trichotillomania, see http://www.promentispharma.com/technology/trichotillomania/

For further information, please contact:Promentis PharmaceuticalsChad E. Beyer, PhD(e) cbeyer@promentispharma.com 

Media Contact:Tiberend Strategic Advisors, Inc.Janine McCargo(t) 646-604-5150(e) jmccargo@tiberend.com

Cision View original content:http://www.prnewswire.com/news-releases/promentis-pharmaceuticals-to-present-at-the-society-for-neuroscience-conference-300739038.html

SOURCE Promentis Pharmaceuticals, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store